Proteomics International awarded $400,000 to support manufacturing capability in Australia
28/04/2022Appendix 4C – March 2022 Quarterly Update
12/04/2022New Clinical Advisory Board for PromarkerD global rollout
07/04/2022Investor Presentation – Perth Healthcare Summit
24/03/2022PromarkerD patent granted in India
10/03/2022Investor Presentation
24/02/2022Appendix 4D and Interim Financial Report
22/02/2022PromarkerD completes ‘pre-assessment’ for Medicare rebate
07/02/2022Novel biomarkers identified for Asthma and COPD
04/02/2022Unique panel of biomarkers identified for oesophageal cancer
28/01/2022Appendix 4C – December 2021 Quarterly Update